| Authors: |
Wynne E; School of Chemical and Process Engineering, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K., Connell SD; Bragg Centre for Materials Research, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K.; School of Physics and Astronomy, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K., Shinebaum R; AstraZeneca, Technical Operations Science & Innovation, Pharmaceutical Technology & Development, Operations, Macclesfield SK10 2NA, U.K., Blade H; AstraZeneca, Oral Product Development, Pharmaceutical Technology & Development, Operations, Macclesfield SK10 2NA, U.K., George N; School of Chemical and Process Engineering, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K.; Syngenta, Jealott's Hill, Warfield, Bracknell RG42 6EY, U.K., Brown A; School of Chemical and Process Engineering, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K., Collins SM; School of Chemical and Process Engineering, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K.; Bragg Centre for Materials Research, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K.; School of Chemistry, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K. |
